Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.10−0.11 (-9.09%)
Close on Nov 18, 2026Market cap $69.75MP/E –Yield –
Equillium net income
Net income is the profit left for shareholders after every expense, interest and tax.
Equillium's net income for the twelve months ending Jun 30, 2026 was -$18.01M. For fiscal 2025 it was -$22.40M. The highest annual figure on record is -$8.07M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.40M | – |
| FY2024 | Dec 31, 2024 | -$8.07M | – |
| FY2023 | Dec 31, 2023 | -$13.34M | – |
| FY2022 | Dec 31, 2022 | -$62.43M | – |
| FY2021 | Dec 31, 2021 | -$39.05M | – |
| FY2020 | Dec 31, 2020 | -$29.81M | – |
| FY2019 | Dec 31, 2019 | -$25.60M | – |
| FY2018 | Dec 31, 2018 | -$13.25M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.69M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.78M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.74M | -1326.3% |
| Q1 FY2025 | Mar 31, 2025 | -$8.65M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.79M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $468.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.73M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.34M | -184.5% |
| Q3 FY2023 | Sep 30, 2023 | -$3.71M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.34M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.94M | – |
| Q4 FY2022 | Dec 31, 2022 | $2.77M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.66M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$37.42M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.62M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.28M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.16M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.99M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.92M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.60M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.46M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.84M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.57M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.01M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.07M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.95M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.99M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.92M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.77M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.58M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.11M | – |
| Q3 FY2017 | Sep 30, 2017 | -$141.03K | – |
| Q2 FY2017 | Jun 30, 2017 | -$947.30K | – |
See a number that looks wrong?